Neuphoria Therapeutics Inc (NEUP)

$3.15 +0.14 (4.65%)
Market Cap 4.90M
Revenue (ttm) 0.00
Net Income (ttm) -15.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 30,000
Avg Vol 1,044,643
Day's Range N/A - N/A
Shares Out 1.63M
Stochastic %K 6%
Beta 0.26
Analysts Strong Sell
Price Target $4.00

Latest News on NEUP

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

Dec 23, 2024, 4:49 PM EST - 25 days ago

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq